New Drug for Substantial Unmet Need Added to Pipeline
Filed with ASX · · 4 pages · English
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- PYCs Lead Drug Effective in Patient Derived Models Tested
- Second Potential Blockbuster Drug Added to PYCs Pipeline
- Creation of Novel Gene Therapy Delivery Technology
- Appendix 4E Preliminary Final Report
- Executive re-structure across global operations
Later from PYC Therapeutics
- PYC Equity Raising to Raise up to $55 Million
- PYC Business and Equity Raising Presentation
- Successful Institutional Entitlement Offer and Placement
- Review of Activities and Appendix 4C
- Visual Evidence of Lead Drugs Efficacy
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics